Asklepios Kliniken GmbH & Co. KGaA submits request for the implementation of a squeeze-out of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft

Asklepios Kliniken GmbH & Co. KGaA with registered office in Hamburg today submitted the request to the management board of RHÖN-Klinikum Aktiengesellschaft that the general meeting of RHÖN-Klinikum Aktiengesellschaft resolves upon the transfer of the shares of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft to Asklepios Kliniken GmbH & Co. KGaA against payment of an adequate cash compensation (so-called squeeze-out). Asklepios Kliniken GmbH & Co. KGaA holds (indirectly) more than 95 percent of the shares in RHÖN-Klinikum Aktiengesellschaft and is therefore the main shareholder within the meaning of section 327a German Stock Corporation Act (Aktiengesetz – AktG).

Asklepios Kliniken GmbH & Co. KGaA will determine the amount of the cash compensation on the basis of a company valuation. The adequacy of the cash compensation will be reviewed by a court appointed expert auditor. The squeeze-out will become effective upon the adoption of the corresponding resolution by the general meeting of RHÖN-Klinikum Aktiengesellschaft and its registration in the commercial register of the company with the local court (Amtsgericht) Schweinfurt.

The resolution on the squeeze-out is expected to take place at an extraordinary general meeting in January 2027.


Contact:
Norman Dittes
Head of Group Finance

RHÖN-KLINIKUM AG
Group Finance
Schlossplatz 1 • 97616 Bad Neustadt a. d. Saale
Tel.: +49 9771 65-12210